Expert corporate advice helps secure £7m investment for cutting edge technology provider

Global growth for Chemigraphic and continued development of its high-tech expertise will be supported by the £7m private equity investment in the technology firm by NVM, backed by legal advice from Robert Rice, partner in our corporate team.

Global growth for Chemigraphic and continued development of its high-tech expertise will be supported by the £7m private equity investment in the technology firm by NVM, backed by legal advice from Robert Rice, partner in our corporate team in Thames Valley.

Chemigraphic’s CEO Chris Wootton, with members of the firm’s management team, came to Rob for advice around the investment, knowing that it would accelerate growth to enable them to stay at the forefront of their industry and to help realise the firm’s future potential.

Chemigraphic is the leading provider of Electronic Manufacturing Services (EMS) to the fast-developing medical technology, defence and power systems sectors. They design and manufacture systems across these sectors, including life-critical medical products for corporate and SME OEMs in the UK and internationally.

Based in West Sussex, the firm has a sourcing office in China, and a 150-strong workforce in the UK.

Chris Wootton, CEO of Chemigraphic said:

“I hadn’t worked with Harrison Clark Rickerbys before but, having done so, I’m very happy to recommend Rob and his team.

“What I really liked was that Rob was on the job himself throughout and didn’t just pass us down to a junior colleague.

“He made it his job to ensure that the whole process was de-mystified and told us exactly what to expect.

“Rob made sure that all of the legal work streams that we were covering were dealt with really quickly and without any fuss or drama, so that I could get on as far as possible with my day job.


Key contacts involved

Robert Rice, Partner

Corporate

Direct Dial: +44 118 945 0156
Mobile: +44 7786 934 346

How can we help you?

Got a question?

Send us an email

x

Stay up to date

with our recent news


x
LOADING